Skip to main content
Top
Published in: BMC Gastroenterology 1/2012

Open Access 01-12-2012 | Research article

Green tea consumption and risk of esophageal cancer: a meta-analysis of epidemiologic studies

Authors: Ping Zheng, Hai-ming Zheng, Xing-ming Deng, Yang-de Zhang

Published in: BMC Gastroenterology | Issue 1/2012

Login to get access

Abstract

Background

Green tea has shown the role of chemoprevention for cancer. Recently, several studies suggested that green tea intake may have effect on esophageal cancer risk, whereas the results were inconsistent.

Methods

We performed a meta-analysis of all English and Chinese language studies of green tea consumption and esophageal cancer risk indexed in Medline, Embase, the Science Citation Index, the Chinese Biomedical Database and Wanfang Data from 1980 to June 2012. After reviewing each study, extracting data, and evaluating heterogeneity (Chi-square-based Q test and Ι2) and publication bias (Begg and Egger test), a meta-analysis was performed to evaluate the association between high/medium/low green tea consumption and non-drinking esophageal cancer risk. Pooled relative risk (RR) or odds ratio (OR) with 95% confidence intervals (CIs) were calculated using the fixed- or random-effect models.

Results

Ten eligible epidemiologic studies including 33731 participants and 3557 cases for esophageal cancer were included. Eight of which were case–control studies, and two were cohort studies. Overall, there were no association between high/medium/low green tea consumption and non-drinking risk of esophageal cancer (High: highest vs non-drinker: RR/OR = 0.76, 95% CI: 0.49 to 1.02. Medium: drinker vs non-drinker: RR/OR = 0.86, 95% CI: 0.70 to 1.03. Low: lowest vs non-drinker: RR/OR = 0.83, 95% CI: 0.58 to 1.08). When stratified analyses according to study design (case–control and cohort studies), country (China and Japan), participates source (population-based and hospital-based case–control), and gender (female and male), there were significant association between high/medium/low green tea consumption and non-drinking risk of esophageal cancer among female (High: RR/OR = 0.32, 95% CI: 0.10 to 0.54. Medium: RR/OR = 0.43, 95% CI: 0.21 to 0.66. Low: RR/OR = 0.45, 95% CI: 0.10 to 0.79), but not the others.

Conclusions

We did not found significant association between green tea consumption and non-drinking esophageal cancer risk, but an evidence of protective effect was observed among female.
Appendix
Available only for authorised users
Literature
1.
go back to reference Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin. 2005, 55: 74-108. 10.3322/canjclin.55.2.74.CrossRefPubMed Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin. 2005, 55: 74-108. 10.3322/canjclin.55.2.74.CrossRefPubMed
2.
go back to reference Hu J, Nyren O, Wolk A, Bergstrom R, Yuen J, Adami HO, Guo L, Li H, Huang G, Xu X: Risk factors for oesophageal cancer in northeast China. Int J Cancer. 1994, 57: 38-46.CrossRefPubMed Hu J, Nyren O, Wolk A, Bergstrom R, Yuen J, Adami HO, Guo L, Li H, Huang G, Xu X: Risk factors for oesophageal cancer in northeast China. Int J Cancer. 1994, 57: 38-46.CrossRefPubMed
3.
go back to reference Castellsague X, Munoz N, De Stefani E, Victora CG, Castelletto R, Rolon PA, Quintana MJ: Independent and joint effects of tobacco smoking and alcohol drinking on the risk of esophageal cancer in men and women. Int J Cancer. 1999, 82: 657-664. 10.1002/(SICI)1097-0215(19990827)82:5<657::AID-IJC7>3.0.CO;2-C.CrossRefPubMed Castellsague X, Munoz N, De Stefani E, Victora CG, Castelletto R, Rolon PA, Quintana MJ: Independent and joint effects of tobacco smoking and alcohol drinking on the risk of esophageal cancer in men and women. Int J Cancer. 1999, 82: 657-664. 10.1002/(SICI)1097-0215(19990827)82:5<657::AID-IJC7>3.0.CO;2-C.CrossRefPubMed
4.
go back to reference Kuriyama S, Shimazu T, Ohmori K, Kikuchi N, Nakaya N, Nishino Y, Tsubono Y, Tsuji I: Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA. 2006, 296: 1255-1265. 10.1001/jama.296.10.1255.CrossRefPubMed Kuriyama S, Shimazu T, Ohmori K, Kikuchi N, Nakaya N, Nishino Y, Tsubono Y, Tsuji I: Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA. 2006, 296: 1255-1265. 10.1001/jama.296.10.1255.CrossRefPubMed
5.
go back to reference Khan WA, Wang ZY, Athar M, Bickers DR, Mukhtar H: Inhibition of the skin tumorigenecity of (1/2)-7 beta, 8 alpha-dihidroxy-9 alpha, 10 alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene by tannic acid, green tea polyphenols and quercetin in Senca mice. Cancer Lett. 1998, 42: 7-12.CrossRef Khan WA, Wang ZY, Athar M, Bickers DR, Mukhtar H: Inhibition of the skin tumorigenecity of (1/2)-7 beta, 8 alpha-dihidroxy-9 alpha, 10 alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene by tannic acid, green tea polyphenols and quercetin in Senca mice. Cancer Lett. 1998, 42: 7-12.CrossRef
6.
go back to reference Yang CS, Lee MJ, Chen L, Yang GY: Polyphenols as inhibitors of carcinogenesis. Environ Health Perspect. 1997, 105 (Suppl 4): 971-976. 10.1289/ehp.97105s4971.CrossRefPubMedPubMedCentral Yang CS, Lee MJ, Chen L, Yang GY: Polyphenols as inhibitors of carcinogenesis. Environ Health Perspect. 1997, 105 (Suppl 4): 971-976. 10.1289/ehp.97105s4971.CrossRefPubMedPubMedCentral
7.
go back to reference Gao YT, McLaughlin JK, Blot WJ, Ji BT, Dai Q, Fraumeni JF: Reduced risk of esophageal cancer associated with green tea consumption. J Natl Cancer Inst. 1994, 86: 855-858. 10.1093/jnci/86.11.855.CrossRefPubMed Gao YT, McLaughlin JK, Blot WJ, Ji BT, Dai Q, Fraumeni JF: Reduced risk of esophageal cancer associated with green tea consumption. J Natl Cancer Inst. 1994, 86: 855-858. 10.1093/jnci/86.11.855.CrossRefPubMed
8.
go back to reference Mu LN, Zhou XF, Ding BG, Wang RH, Zhang ZF, Jiang QW, Yu SZ: Study on the protective effect of green tea on gastric, liver and esophageal cancers. Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]. 2003, 37: 171-173. Mu LN, Zhou XF, Ding BG, Wang RH, Zhang ZF, Jiang QW, Yu SZ: Study on the protective effect of green tea on gastric, liver and esophageal cancers. Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]. 2003, 37: 171-173.
9.
go back to reference Wu M, Liu AM, Kampman E, Zhang ZF, Van't Veer P, Wu DL, Wang PH, Yang J, Qin Y, Mu LN, Kok FJ, Zhao JK: Green tea drinking, high tea temperature and esophageal cancer in high- and low-risk areas of Jiangsu Province, China: a population-based case–control study. Int J Cancer. 2009, 124: 1907-1913. 10.1002/ijc.24142.CrossRefPubMed Wu M, Liu AM, Kampman E, Zhang ZF, Van't Veer P, Wu DL, Wang PH, Yang J, Qin Y, Mu LN, Kok FJ, Zhao JK: Green tea drinking, high tea temperature and esophageal cancer in high- and low-risk areas of Jiangsu Province, China: a population-based case–control study. Int J Cancer. 2009, 124: 1907-1913. 10.1002/ijc.24142.CrossRefPubMed
10.
go back to reference Mantel N, Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959, 22: 719-748.PubMed Mantel N, Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959, 22: 719-748.PubMed
11.
go back to reference ErSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials. 1986, 7: 177-188. 10.1016/0197-2456(86)90046-2.CrossRef ErSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials. 1986, 7: 177-188. 10.1016/0197-2456(86)90046-2.CrossRef
12.
go back to reference Hedges LV, Pigott TD: The power of statistical tests in meta-analysis. Psychol Methods. 2001, 6: 203-217.CrossRefPubMed Hedges LV, Pigott TD: The power of statistical tests in meta-analysis. Psychol Methods. 2001, 6: 203-217.CrossRefPubMed
13.
go back to reference DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials. 1986, 7: 177-188. 10.1016/0197-2456(86)90046-2.CrossRefPubMed DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials. 1986, 7: 177-188. 10.1016/0197-2456(86)90046-2.CrossRefPubMed
14.
go back to reference Begg CB, Mazumdar M: Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994, 50: 1088-1101. 10.2307/2533446.CrossRefPubMed Begg CB, Mazumdar M: Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994, 50: 1088-1101. 10.2307/2533446.CrossRefPubMed
15.
go back to reference Egger M, Davey Smith G, Schneider M, Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997, 315: 629-634. 10.1136/bmj.315.7109.629.CrossRefPubMedPubMedCentral Egger M, Davey Smith G, Schneider M, Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997, 315: 629-634. 10.1136/bmj.315.7109.629.CrossRefPubMedPubMedCentral
16.
go back to reference Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB: Meta-analysis of observational studies in epidemiology: A proposal for reporting. JAMA. 2000, 283: 2008-2012. 10.1001/jama.283.15.2008.CrossRefPubMed Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB: Meta-analysis of observational studies in epidemiology: A proposal for reporting. JAMA. 2000, 283: 2008-2012. 10.1001/jama.283.15.2008.CrossRefPubMed
17.
go back to reference Ishikawa A, Kuriyama S, Tsubono Y, Fukao A, Takahashi H, Tachiya H, Tsuji I: Smoking, alcohol drinking, green tea consumption and the risk of esophageal cancer in Japanese men. J Epidemiol. 2006, 16: 185-192. 10.2188/jea.16.185.CrossRefPubMed Ishikawa A, Kuriyama S, Tsubono Y, Fukao A, Takahashi H, Tachiya H, Tsuji I: Smoking, alcohol drinking, green tea consumption and the risk of esophageal cancer in Japanese men. J Epidemiol. 2006, 16: 185-192. 10.2188/jea.16.185.CrossRefPubMed
18.
go back to reference Wang JM, Xu B, Rao JY, Shen HB, Xue HC, Jiang QW: Diet habits, alcohol drinking, tobacco smoking, green tea drinking, and the risk of esophageal squamous cell carcinoma in the Chinese population. Eur J Gastroenterol Hepatol. 2007, 19: 171-176. 10.1097/MEG.0b013e32800ff77a.CrossRefPubMed Wang JM, Xu B, Rao JY, Shen HB, Xue HC, Jiang QW: Diet habits, alcohol drinking, tobacco smoking, green tea drinking, and the risk of esophageal squamous cell carcinoma in the Chinese population. Eur J Gastroenterol Hepatol. 2007, 19: 171-176. 10.1097/MEG.0b013e32800ff77a.CrossRefPubMed
19.
go back to reference Chen Z, Chen Q, Xia H, Lin J: Green tea drinking habits and esophageal cancer in southern China: a case–control study. Asian Pac J Cancer Prev. 2011, 12: 229-233.PubMed Chen Z, Chen Q, Xia H, Lin J: Green tea drinking habits and esophageal cancer in southern China: a case–control study. Asian Pac J Cancer Prev. 2011, 12: 229-233.PubMed
20.
go back to reference Jilong Y, Mingrong W, Chunhua G, Maosheng L, Guopei Y, Xingsheng G, Guiping C: Green Tea and Cancer of Esophagus and Stomach: a Case Control Study. Chin J Pubc Health. 1999, 6: 367-368. Jilong Y, Mingrong W, Chunhua G, Maosheng L, Guopei Y, Xingsheng G, Guiping C: Green Tea and Cancer of Esophagus and Stomach: a Case Control Study. Chin J Pubc Health. 1999, 6: 367-368.
21.
go back to reference Islami F, Pourshams A, Nasrollahzadeh D, Kamangar F, Fahimi S, Shakeri R, Abedi-Ardekani B, Merat S, Vahedi H, Semnani S, Abnet CC, Brennan P, Møller H, Saidi F, Dawsey SM, Malekzadeh R, Boffetta P: Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case–control study. BMJ. 2009, 338: b929-10.1136/bmj.b929.CrossRefPubMedPubMedCentral Islami F, Pourshams A, Nasrollahzadeh D, Kamangar F, Fahimi S, Shakeri R, Abedi-Ardekani B, Merat S, Vahedi H, Semnani S, Abnet CC, Brennan P, Møller H, Saidi F, Dawsey SM, Malekzadeh R, Boffetta P: Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case–control study. BMJ. 2009, 338: b929-10.1136/bmj.b929.CrossRefPubMedPubMedCentral
22.
go back to reference Kobayashi K: Effect of sex hormone on the experimental induction of esophageal cancer. Nihon Geka Gakkai Zasshi. 1985, 86: 280-289.PubMed Kobayashi K: Effect of sex hormone on the experimental induction of esophageal cancer. Nihon Geka Gakkai Zasshi. 1985, 86: 280-289.PubMed
23.
go back to reference Matsuoka H, Sugimachi K, Ueo H, Kuwano H, Nakano S, Nakayama M: Sex hormone response of a newly established squamous cell line derived from clinical esophageal carcinoma. Cancer Res. 1987, 47: 4134-4140.PubMed Matsuoka H, Sugimachi K, Ueo H, Kuwano H, Nakano S, Nakayama M: Sex hormone response of a newly established squamous cell line derived from clinical esophageal carcinoma. Cancer Res. 1987, 47: 4134-4140.PubMed
24.
go back to reference Li ZG, Shimada Y, Sato F, Maeda M, Itami A, Kaganoi J, Komoto I, Kawabe A, Imamura M: Promotion effects of hot water on N-nitrosomethylbenzylamine-induced esophageal tumorigenesis in F344 rats. Oncol Rep. 2003, 10: 421-426.PubMed Li ZG, Shimada Y, Sato F, Maeda M, Itami A, Kaganoi J, Komoto I, Kawabe A, Imamura M: Promotion effects of hot water on N-nitrosomethylbenzylamine-induced esophageal tumorigenesis in F344 rats. Oncol Rep. 2003, 10: 421-426.PubMed
Metadata
Title
Green tea consumption and risk of esophageal cancer: a meta-analysis of epidemiologic studies
Authors
Ping Zheng
Hai-ming Zheng
Xing-ming Deng
Yang-de Zhang
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2012
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/1471-230X-12-165

Other articles of this Issue 1/2012

BMC Gastroenterology 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.